PT1523983E - Suspensão aquosa contendo fenofibrato - Google Patents

Suspensão aquosa contendo fenofibrato Download PDF

Info

Publication number: PT1523983E
Authority: PT; Portugal
Prior art keywords: surfactant; fenofibrate; aqueous suspension; cellulose derivative; micronized fenofibrate
Prior art date: 1999-07-09

Application number

PT04027226T

Other languages

English (en)

Inventor

Pascal Suplie

Philippe Chenevier

Bruno Criere

Original Assignee

Ethypharm Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-07-09

Filing date

2000-07-07

Publication date

2008-09-19

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9547923&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT1523983(E) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2000-07-07 Application filed by Ethypharm Sa filed Critical Ethypharm Sa

2008-09-19 Publication of PT1523983E publication Critical patent/PT1523983E/pt

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
- A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Biophysics (AREA)
Diabetes (AREA)
Hematology (AREA)
Molecular Biology (AREA)
Emergency Medicine (AREA)
Obesity (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)
Agricultural Chemicals And Associated Chemicals (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)

PT04027226T 1999-07-09 2000-07-07 Suspensão aquosa contendo fenofibrato PT1523983E (pt)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
FR9908923A FR2795961B1 (fr)	1999-07-09	1999-07-09	Composition pharmaceutique contenant du fenofibrate micronise, un tensioactif et un derive cellulosique liant et procede de preparation

Publications (1)

Publication Number	Publication Date
PT1523983E true PT1523983E (pt)	2008-09-19

Family

ID=9547923

Family Applications (3)

Application Number	Title	Priority Date	Filing Date
PT05006751T PT1574214E (pt)	1999-07-09	2000-07-07	Composição farmacêutica que contém fenofibrato e processo para a sua preparação
PT00949677T PT1194140E (pt)	1999-07-09	2000-07-07	Composicao farmaceutica contendo fenofibrato e processo de preparacao
PT04027226T PT1523983E (pt)	1999-07-09	2000-07-07	Suspensão aquosa contendo fenofibrato

Family Applications Before (2)

Application Number	Title	Priority Date	Filing Date
PT05006751T PT1574214E (pt)	1999-07-09	2000-07-07	Composição farmacêutica que contém fenofibrato e processo para a sua preparação
PT00949677T PT1194140E (pt)	1999-07-09	2000-07-07	Composicao farmaceutica contendo fenofibrato e processo de preparacao

Country Status (37)

Country	Link
US (4)	US7101574B1 (pt)
EP (3)	EP1194140B1 (pt)
JP (2)	JP4841092B2 (pt)
KR (3)	KR20020025188A (pt)
CN (2)	CN1682707B (pt)
AT (3)	ATE291912T1 (pt)
AU (1)	AU782282B2 (pt)
BG (1)	BG65504B1 (pt)
BR (1)	BR0012335A (pt)
CA (1)	CA2377909C (pt)
CY (1)	CY1106206T1 (pt)
CZ (1)	CZ300094B6 (pt)
DE (3)	DE60019120T2 (pt)
DK (3)	DK1194140T3 (pt)
EA (1)	EA004294B1 (pt)
EE (1)	EE04995B1 (pt)
ES (3)	ES2309438T3 (pt)
FR (1)	FR2795961B1 (pt)
GE (1)	GEP20043287B (pt)
HK (3)	HK1044894B (pt)
HR (1)	HRP20020111B1 (pt)
HU (1)	HU229044B1 (pt)
IL (2)	IL147499A0 (pt)
IS (1)	IS2157B (pt)
ME (1)	ME01361B (pt)
MX (1)	MXPA02000324A (pt)
NO (1)	NO333301B1 (pt)
NZ (1)	NZ516416A (pt)
PL (1)	PL212082B1 (pt)
PT (3)	PT1574214E (pt)
RS (1)	RS50035B (pt)
SI (2)	SI1194140T1 (pt)
SK (1)	SK287484B6 (pt)
TR (1)	TR200200008T2 (pt)
UA (1)	UA72925C2 (pt)
WO (1)	WO2001003693A1 (pt)
ZA (1)	ZA200200169B (pt)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7863331B2 (en)	1999-07-09	2011-01-04	Ethypharm	Pharmaceutical composition containing fenofibrate and method for the preparation thereof
FR2795961B1 (fr) *	1999-07-09	2004-05-28	Ethypharm Lab Prod Ethiques	Composition pharmaceutique contenant du fenofibrate micronise, un tensioactif et un derive cellulosique liant et procede de preparation
US20080241070A1 (en) *	2000-09-21	2008-10-02	Elan Pharma International Ltd.	Fenofibrate dosage forms
FR2819720B1 (fr) *	2001-01-22	2004-03-12	Fournier Lab Sa	Nouveaux comprimes de fenofibrate
GB0119480D0 (en)	2001-08-09	2001-10-03	Jagotec Ag	Novel compositions
SI1551372T1 (en) *	2002-09-20	2018-08-31	Alpharma Pharmaceuticals Llc	SUBVENCATION DATA AND RELATED CONSTRUCTIONS AND PROCEDURES
WO2004028506A1 (en) *	2002-09-24	2004-04-08	Ranbaxy Laboratories Limited	Oral pharmaceutical compositions of fenofibrate having high bioavailability
CN100367947C (zh) *	2002-12-04	2008-02-13	徐州恩华赛德药业有限责任公司	具有抗高血脂症的含非诺贝特的药物组合物
JP2006511541A (ja) *	2002-12-17	2006-04-06	アボットゲーエムベーハーウントカンパニーカーゲー	フェノフィブル酸、その生理学的に許容し得る塩または誘導体を含有してなる製剤
US20080051411A1 (en) *	2002-12-17	2008-02-28	Cink Russell D	Salts of Fenofibric Acid and Pharmaceutical Formulations Thereof
EP1832285A1 (en) *	2002-12-17	2007-09-12	Abbott GmbH & Co. KG	Formulation comprising fenofibric acid or a physiologically acceptable salt thereof
WO2005002541A2 (en) *	2003-07-02	2005-01-13	Abbott Laboratories	Process for preparing formulations of lipid-regulating drugs
US7264813B2 (en)	2003-09-24	2007-09-04	Nikken Sohonsha Corporation	Therapeutic uses of Dunaliella powder
US8062664B2 (en)	2003-11-12	2011-11-22	Abbott Laboratories	Process for preparing formulations of lipid-regulating drugs
US8026281B2 (en) *	2004-10-14	2011-09-27	Lupin Atlantis Holdings, S.A.	Treating metabolic syndrome with fenofibrate
EP2281556A1 (en) *	2005-02-25	2011-02-09	F. Hoffmann-La Roche AG	Tablets with improved drugs substance dispersibility
EA200701750A1 (ru) *	2005-03-30	2008-02-28	Тева Фармасьютикал Индастриес Лтд.	Улучшенные составы фенофибрата, содержащие ментол или пэг/полоксамер
US20080152714A1 (en) *	2005-04-08	2008-06-26	Yi Gao	Pharmaceutical Formulations
US20090210197A1 (en) *	2006-05-23	2009-08-20	Intelemetrix Ltd	Data accessing system and method
KR20150029762A (ko)	2006-06-19	2015-03-18	알파마 파머슈티컬스 엘엘씨	약제학적 조성물
KR100767349B1 (ko) *	2006-08-01	2007-10-17	삼천당제약주식회사	페노피브레이트를 함유하는 경구용 약제 조성물 및 그의제조방법
EP1923053A1 (en) *	2006-09-27	2008-05-21	Novartis AG	Pharmaceutical compositions comprising nilotinib or its salt
US20080233156A1 (en) *	2006-10-11	2008-09-25	Alpharma, Inc.	Pharmaceutical compositions
JP4993274B2 (ja) *	2006-12-05	2012-08-08	日医工株式会社	フェノフィブラート含有製剤組成物の製造方法
EP2224805A4 (en) *	2007-12-17	2013-10-16	Alpharma Pharmaceuticals Llc	PHARMACEUTICAL COMPOSITION
US8623418B2 (en)	2007-12-17	2014-01-07	Alpharma Pharmaceuticals Llc	Pharmaceutical composition
FR2940118B1 (fr) *	2008-12-24	2013-08-09	Ethypharm Sa	Formulation pharmaceutique de fenofibrate nanonise
WO2010092925A1 (ja) *	2009-02-12	2010-08-19	あすか製薬株式会社	固体分散体とその医薬組成物、並びにそれらの製造方法
CN101502497B (zh) *	2009-03-06	2010-11-10	安徽省药物研究所	非诺贝特药物组合物
US20100291201A1 (en) *	2009-05-14	2010-11-18	Cerovene, Inc.	Coated pharmaceutical capsule dosage form
KR101202994B1 (ko) *	2010-04-12	2012-11-21	한미사이언스 주식회사	페노피브린산 및 알칼리화제를 포함하는 경구용 약학 조성물
US20140255480A1 (en) *	2011-09-07	2014-09-11	Ethypharm	Pharmaceutical formulation of nanonized fenofibrate
KR101334585B1 (ko) *	2012-05-29	2013-12-05	주식회사 브이터치	프로젝터를 통해 표시되는 정보를 이용하여 가상터치를 수행하는 원격 조작 장치 및 방법
US8722083B2 (en)	2012-06-25	2014-05-13	Mylan, Inc.	Fenofibrate formulation
WO2014091318A1 (en)	2012-12-11	2014-06-19	Lupin Atlantis Holdings, S.A.	Reduced dose pharmaceutical compositions of fenofibrate
BR112016011628A2 (pt) *	2013-12-04	2017-08-08	Dow Global Technologies Llc	Processo para preparar uma mistura de um derivado de celulose e um diluente líquido
CN104352466A (zh) *	2014-11-17	2015-02-18	辰欣药业股份有限公司	一种非诺贝特组合物及其制剂
CN107961224B (zh) *	2017-12-06	2021-05-04	齐鲁制药(海南)有限公司	一种阿昔替尼片及其制备方法
KR102407512B1 (ko)	2019-10-30	2022-06-13	주식회사 대웅테라퓨틱스	피브레이트계 화합물을 포함하는 근육 질환 예방 및 치료용 조성물
CN112121022A (zh) *	2020-09-25	2020-12-25	迪沙药业集团有限公司	一种非诺贝特片组合物及其制备方法
WO2022071768A1 (en) *	2020-09-29	2022-04-07	Addpharma Inc.	A pharmaceutical composition comprising fenofibrate particles with improved bioavailability
CN112121023A (zh) *	2020-09-30	2020-12-25	迪沙药业集团有限公司	一种非诺贝特片组合物

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CH543472A (fr)	1969-01-31	1973-10-31	Orchimed Sa	Procédé pour la préparation d'acides phénoxyalcoyl-carboxyliques
US4058552A (en)	1969-01-31	1977-11-15	Orchimed Sa	Esters of p-carbonylphenoxy-isobutyric acids
GB1579818A (en)	1977-06-07	1980-11-26	Yamanouchi Pharma Co Ltd	Nifedipine-containing solid preparation composition
ATE5852T1 (de)	1978-11-20	1984-02-15	American Home Products Corporation	Therapeutische zusammensetzungen mit gesteigerter bioverfuegbarkeit und verfahren zu deren herstellung.
US4344934A (en) *	1978-11-20	1982-08-17	American Home Products Corporation	Therapeutic compositions with enhanced bioavailability
FR2494112B1 (pt)	1980-11-19	1986-01-10	Laruelle Claude
GB8414221D0 (en)	1984-06-04	1984-07-11	Sterwin Ag	Unit dosage form
GB8414220D0 (en)	1984-06-04	1984-07-11	Sterwin Ag	Medicaments in unit dose form
FR2602423B1 (fr) *	1986-08-08	1989-05-05	Ethypharm Sa	Procede de preparation d'un medicament a base de fenofibrate, medicament obtenu par ce procede
US4752470A (en)	1986-11-24	1988-06-21	Mehta Atul M	Controlled release indomethacin
US4895725A (en) *	1987-08-24	1990-01-23	Clinical Technologies Associates, Inc.	Microencapsulation of fish oil
FR2627696B1 (fr)	1988-02-26	1991-09-13	Fournier Innovation Synergie	Nouvelle forme galenique du fenofibrate
WO1992000064A1 (de)	1990-07-02	1992-01-09	Boehringer Mannheim Gmbh	Verfahren zur herstellung geformter, verpresster dosiseinheiten mit retardierter freisetzung und entsprechende dosiseinheit
JP3125221B2 (ja) *	1990-09-01	2001-01-15	大正製薬株式会社	ソファルコン含有固形製剤
JP3037393B2 (ja) *	1990-10-22	2000-04-24	大正薬品工業株式会社	経口投与用固形薬剤の製造方法
US5145684A (en)	1991-01-25	1992-09-08	Sterling Drug Inc.	Surface modified drug nanoparticles
US5223268A (en) *	1991-05-16	1993-06-29	Sterling Drug, Inc.	Low solubility drug-coated bead compositions
DE69127275T2 (de) *	1991-06-21	1998-03-12	Ilsan Ilac Ve Hammaddeleri San	Neues galenisches Verfahren für Omeprazol enthaltende Pellets
SE9402422D0 (sv)	1994-07-08	1994-07-08	Astra Ab	New beads for controlled release and a pharmaceutical preparation containing the same
FR2722984B1 (fr)	1994-07-26	1996-10-18	Effik Lab	Procede de preparation de formes pharmaceutiques seches et les compositions pharmaceutiques ainsi realisees
US5545628A (en) *	1995-01-10	1996-08-13	Galephar P.R. Inc.	Pharmaceutical composition containing fenofibrate
US5558879A (en) *	1995-04-28	1996-09-24	Andrx Pharmaceuticals, Inc.	Controlled release formulation for water soluble drugs in which a passageway is formed in situ
DE19608750A1 (de)	1996-03-06	1997-09-11	Durachemie Gmbh & Co Kg	Verfahren zur Herstellung von Fenofibrat-Präparaten
SK177598A3 (en) *	1996-06-28	1999-07-12	Schering Corp	Oral composition comprising a triazole antifungal compound
FR2758459B1 (fr) *	1997-01-17	1999-05-07	Pharma Pass	Composition pharmaceutique de fenofibrate presentant une biodisponibilite elevee et son procede de preparation
FR2758461A1 (fr)	1997-01-17	1998-07-24	Pharma Pass	Composition pharmaceutique presentant une biodisponibilite elevee et son procede de preparation
EP1021525A1 (en) *	1997-12-20	2000-07-26	Genencor International, Inc.	Fluidized bed matrix granule
JP2000086509A (ja) *	1998-09-14	2000-03-28	Taisho Yakuhin Kogyo Kk	ソファルコン含有製剤の製造方法
FR2783421B1 (fr) *	1998-09-17	2000-11-24	Cll Pharma	Procede de preparation de nouvelles formulations galeniques du fenofibrate, formulations galeniques obtenues par ledit procede et leurs applications
US6368620B2 (en) *	1999-06-11	2002-04-09	Abbott Laboratories	Formulations comprising lipid-regulating agents
FR2795961B1 (fr)	1999-07-09	2004-05-28	Ethypharm Lab Prod Ethiques	Composition pharmaceutique contenant du fenofibrate micronise, un tensioactif et un derive cellulosique liant et procede de preparation
US7863331B2 (en) *	1999-07-09	2011-01-04	Ethypharm	Pharmaceutical composition containing fenofibrate and method for the preparation thereof
US6667064B2 (en)	2000-08-30	2003-12-23	Pilot Therapeutics, Inc.	Composition and method for treatment of hypertriglyceridemia
TWI293877B (en) *	2000-09-20	2008-03-01	Rtp Pharma Inc	Spray drying process and compositions of fenofibrate
US8026281B2 (en) *	2004-10-14	2011-09-27	Lupin Atlantis Holdings, S.A.	Treating metabolic syndrome with fenofibrate

1999
- 1999-07-09 FR FR9908923A patent/FR2795961B1/fr not_active Expired - Lifetime
2000
- 2000-07-07 CN CN2005100648532A patent/CN1682707B/zh not_active Expired - Lifetime
- 2000-07-07 EP EP00949677A patent/EP1194140B1/fr not_active Expired - Lifetime
- 2000-07-07 MX MXPA02000324A patent/MXPA02000324A/es active IP Right Grant
- 2000-07-07 UA UA2002021052A patent/UA72925C2/uk unknown
- 2000-07-07 EE EEP200200011A patent/EE04995B1/xx unknown
- 2000-07-07 CA CA2377909A patent/CA2377909C/fr not_active Expired - Lifetime
- 2000-07-07 AT AT00949677T patent/ATE291912T1/de active
- 2000-07-07 NZ NZ516416A patent/NZ516416A/en not_active IP Right Cessation
- 2000-07-07 AT AT04027226T patent/ATE399006T1/de active
- 2000-07-07 EA EA200200147A patent/EA004294B1/ru not_active IP Right Cessation
- 2000-07-07 AU AU62960/00A patent/AU782282B2/en not_active Expired
- 2000-07-07 SI SI200030633T patent/SI1194140T1/xx unknown
- 2000-07-07 DE DE60019120T patent/DE60019120T2/de not_active Expired - Lifetime
- 2000-07-07 RS YUP-932/01A patent/RS50035B/sr unknown
- 2000-07-07 EP EP05006751A patent/EP1574214B1/fr not_active Expired - Lifetime
- 2000-07-07 PT PT05006751T patent/PT1574214E/pt unknown
- 2000-07-07 ME MEP-2001-932A patent/ME01361B/me unknown
- 2000-07-07 GE GEAP20006316A patent/GEP20043287B/en unknown
- 2000-07-07 EP EP04027226A patent/EP1523983B1/fr not_active Expired - Lifetime
- 2000-07-07 BR BR0012335-8A patent/BR0012335A/pt not_active Application Discontinuation
- 2000-07-07 ES ES04027226T patent/ES2309438T3/es not_active Expired - Lifetime
- 2000-07-07 KR KR1020027000329A patent/KR20020025188A/ko not_active Application Discontinuation
- 2000-07-07 SI SI200030894T patent/SI1574214T1/sl unknown
- 2000-07-07 WO PCT/FR2000/001971 patent/WO2001003693A1/fr not_active Application Discontinuation
- 2000-07-07 DK DK00949677T patent/DK1194140T3/da active
- 2000-07-07 PT PT00949677T patent/PT1194140E/pt unknown
- 2000-07-07 US US10/030,262 patent/US7101574B1/en not_active Expired - Lifetime
- 2000-07-07 PT PT04027226T patent/PT1523983E/pt unknown
- 2000-07-07 IL IL14749900A patent/IL147499A0/xx active IP Right Grant
- 2000-07-07 JP JP2001508973A patent/JP4841092B2/ja not_active Expired - Lifetime
- 2000-07-07 PL PL352307A patent/PL212082B1/pl unknown
- 2000-07-07 CZ CZ20020002A patent/CZ300094B6/cs not_active IP Right Cessation
- 2000-07-07 AT AT05006751T patent/ATE341320T1/de active
- 2000-07-07 DK DK05006751T patent/DK1574214T3/da active
- 2000-07-07 DK DK04027226T patent/DK1523983T3/da active
- 2000-07-07 SK SK15-2002A patent/SK287484B6/sk not_active IP Right Cessation
- 2000-07-07 TR TR2002/00008T patent/TR200200008T2/xx unknown
- 2000-07-07 HU HU0202338A patent/HU229044B1/hu not_active IP Right Cessation
- 2000-07-07 DE DE60031184T patent/DE60031184T2/de not_active Expired - Lifetime
- 2000-07-07 DE DE60039313T patent/DE60039313D1/de not_active Expired - Lifetime
- 2000-07-07 CN CNB008101469A patent/CN1204885C/zh not_active Expired - Lifetime
- 2000-07-07 ES ES00949677T patent/ES2235919T3/es not_active Expired - Lifetime
- 2000-07-07 ES ES05006751T patent/ES2271924T3/es not_active Expired - Lifetime
2002
- 2002-01-02 NO NO20020014A patent/NO333301B1/no not_active IP Right Cessation
- 2002-01-03 IS IS6218A patent/IS2157B/is unknown
- 2002-01-04 BG BG106280A patent/BG65504B1/bg unknown
- 2002-01-07 IL IL147499A patent/IL147499A/en unknown
- 2002-01-09 ZA ZA200200169A patent/ZA200200169B/en unknown
- 2002-02-05 HR HR20020111A patent/HRP20020111B1/xx not_active IP Right Cessation
- 2002-08-30 HK HK02106433.0A patent/HK1044894B/zh not_active IP Right Cessation
2005
- 2005-10-04 HK HK05108777A patent/HK1074588A1/xx not_active IP Right Cessation
2006
- 2006-03-09 HK HK06103039A patent/HK1080391A1/xx not_active IP Right Cessation
- 2006-05-29 KR KR1020060048212A patent/KR20060073549A/ko not_active Application Discontinuation
- 2006-08-25 US US11/509,806 patent/US8658212B2/en not_active Expired - Lifetime
- 2006-10-18 CY CY20061101495T patent/CY1106206T1/el unknown
2007
- 2007-02-02 KR KR1020070010902A patent/KR100766644B1/ko active IP Right Grant
2008
- 2008-06-11 US US12/155,937 patent/US20080248101A1/en not_active Abandoned
2010
- 2010-06-25 US US12/823,900 patent/US8563042B2/en not_active Expired - Fee Related
2011
- 2011-03-15 JP JP2011057117A patent/JP2011148813A/ja active Pending

Also Published As

Publication number	Publication date
KR20070026716A (ko)	2007-03-08
BG65504B1 (bg)	2008-10-31
JP2011148813A (ja)	2011-08-04
DK1194140T3 (da)	2005-07-04
IS6218A (is)	2002-01-03
SK152002A3 (en)	2002-07-02
US20080248101A1 (en)	2008-10-09
JP4841092B2 (ja)	2011-12-21
ES2309438T3 (es)	2008-12-16
NO20020014D0 (no)	2002-01-02
ATE399006T1 (de)	2008-07-15
CN1360499A (zh)	2002-07-24
AU782282B2 (en)	2005-07-14
EP1574214A1 (fr)	2005-09-14
PT1574214E (pt)	2007-01-31
NO333301B1 (no)	2013-04-29
IL147499A0 (en)	2002-08-14
DE60031184D1 (de)	2006-11-16
HK1044894B (zh)	2005-06-24
US8563042B2 (en)	2013-10-22
US7101574B1 (en)	2006-09-05
HK1080391A1 (en)	2006-04-28
HUP0202338A2 (en)	2002-10-28
RS50035B (sr)	2008-11-28
CN1682707B (zh)	2010-05-05
JP2003504331A (ja)	2003-02-04
CA2377909C (fr)	2011-06-28
ES2271924T3 (es)	2007-04-16
EA004294B1 (ru)	2004-02-26
YU93201A (sh)	2004-09-03
NO20020014L (no)	2002-03-04
ZA200200169B (en)	2002-07-31
FR2795961B1 (fr)	2004-05-28
EA200200147A1 (ru)	2002-06-27
US20070071812A1 (en)	2007-03-29
SI1194140T1 (en)	2005-06-30
HRP20020111A2 (en)	2003-04-30
CZ20022A3 (cs)	2002-05-15
EP1523983A1 (fr)	2005-04-20
EP1194140B1 (fr)	2005-03-30
HU229044B1 (hu)	2013-07-29
HK1074588A1 (en)	2005-11-18
EE04995B1 (et)	2008-04-15
HRP20020111B1 (en)	2005-12-31
KR20060073549A (ko)	2006-06-28
HUP0202338A3 (en)	2003-03-28
HK1044894A1 (en)	2002-11-08
MXPA02000324A (es)	2002-06-21
EP1523983B1 (fr)	2008-06-25
UA72925C2 (uk)	2005-05-16
KR100766644B1 (ko)	2007-10-15
ME01361B (me)	2008-11-28
PT1194140E (pt)	2005-07-29
WO2001003693A1 (fr)	2001-01-18
TR200200008T2 (tr)	2002-06-21
ES2235919T3 (es)	2005-07-16
DE60019120D1 (de)	2005-05-04
US8658212B2 (en)	2014-02-25
DK1574214T3 (da)	2007-01-22
CZ300094B6 (cs)	2009-01-28
PL352307A1 (en)	2003-08-11
ATE291912T1 (de)	2005-04-15
GEP20043287B (en)	2004-07-26
CA2377909A1 (fr)	2001-01-18
ATE341320T1 (de)	2006-10-15
BG106280A (en)	2002-08-30
KR20020025188A (ko)	2002-04-03
EP1574214B1 (fr)	2006-10-04
SI1574214T1 (sl)	2006-12-31
EP1194140A1 (fr)	2002-04-10
EE200200011A (et)	2003-02-17
DK1523983T3 (da)	2008-10-13
DE60039313D1 (de)	2008-08-07
CY1106206T1 (el)	2011-06-08
CN1682707A (zh)	2005-10-19
CN1204885C (zh)	2005-06-08
BR0012335A (pt)	2002-03-19
IL147499A (en)	2007-03-08
DE60019120T2 (de)	2006-02-09
IS2157B (is)	2006-11-15
AU6296000A (en)	2001-01-30
SK287484B6 (sk)	2010-11-08
FR2795961A1 (fr)	2001-01-12
DE60031184T2 (de)	2007-08-23
PL212082B1 (pl)	2012-08-31
US20110159082A1 (en)	2011-06-30
NZ516416A (en)	2003-10-31

Publication	Publication Date	Title
HK1074588A1 (en)	2005-11-18	Aqueous suspension comprising fenofibrate
BG106398A (en)	2002-09-30	Method for making granules with masked taste and instant release of the active particle
WO2001032646A3 (en)	2001-12-27	Sulfonamide derivatives
HUP0103567A3 (en)	2003-01-28	2-substituted-1-piperidyl benzimidazole compounds as orl1-receptor agonists, process for their preparation and pharmaceutical compositions containing the same
WO1999063826A3 (de)	2000-12-21	Mittel zur bekämpfung von pflanzenschädlingen
GB9819272D0 (en)	1998-10-28	Microparticles
WO2001095856A3 (en)	2002-06-27	Urea derivative useful as an anti-cancer agent and process for preparing same
EA199700093A1 (ru)	1998-02-26	ЛЕКАРСТВЕННЫЕ ФОРМЫ ДЛЯ ПЕРОРАЛЬНОГО ВВЕДЕНИЯ, СОДЕРЖАЩИЕ β-ЛАКТАМНЫЙ АНТИБИОТИК
HUP9802995A3 (en)	1999-04-28	Substituted sulphonylamino (thio)carbonyl derivatives, intermediates, thereof herbicide compositions containing these compounds as active ingredients, process for the preparation and use of the compounds and compositions
EP2065451A3 (de)	2009-06-17	Trockenpräparate
BG102555A (en)	1999-02-26	Microgranules of delayed release containing dilthiazem as active component
HUT47794A (en)	1989-04-28	Insecticide, acaricide and nematocide compositions containing pyridazinone derivatives as active components and process for producing the active components
TR199901044T2 (en)	1999-07-21	Endos�lfan-mikrokaps�l da��l�m�.
HUP0004386A3 (en)	2002-08-28	Methylenebisphosphonic acid derivatives, process for producing them and medicaments containing the same as active agent
KR940006583A (ko)	1994-04-25	약제학적 조성물 제조용 보조 혼합물 및 비고체 활성 화합물의 피흡착질
AU1465995A (en)	1995-08-08	N-phenyltetrahydrophthalamic acid derivative, process for producing the same, and herbicide containing the same as active ingredient
AU2178299A (en)	1999-08-16	8-azabicyclo(3.2.1)oct-2-ene derivatives as pesticides
HU9801086D0 (en)	1998-07-28	New benzofurane derivatives, pharmaceutical compositions containing them as active component and process for producing the active component